-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Lexeo Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2022 to Q2 2024.
- Lexeo Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$23.6M, a 68.5% decline year-over-year.
- Lexeo Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$82.1M.
- Lexeo Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$68.5M, a 13.2% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)